Abstract-Treatment of post stroke spasticity represents a major challenge in neurologic rehabilitation. Conventional medication treatment is not enough to control the negative effects of muscle stiffness, lack of movement coordination and control, and consecutive limited range of joint motion especially on affected chronic patients where the immobility-related changes of the mechanical muscle properties are prevailing. Repetitive peripheral magnetic stimulation (rPMS) of affected muscles administered during stretching is a new and attractive option of therapeutical intervention, able to reduce pathological muscle tone and to stimulate cortical reorganization.
functions are to increase stability and to improve muscle tension. Canes and walkers appear to be effective in compensating for patients' decreased postural sway and for enhancing their participation in activities of daily living [2] , especially if they have hemiplegia [3] , [4] . But, the most important rehabilitation intervention approach must be the restorative one, not the assistive one. In order to regain functionality, the stroke survivor has to undergo a complex program of training (physical exercises aided or not by advanced rehabilitation technology) and different physical agents applications, aimed to restore the optimal condition of the nervous and myo-arthrokinetic structures involved in functional movement [5] .
The upper and lower limb muscle stiffness and consecutive limited range of joint motion after stroke can seriously interfere with daily living activities, and has an important influence in quality of life. Three months after stroke for instance, 25% of the surviving patients present an upper limb and 15 % of them -lower limb stiffness [6] , [7] .
Spasticity being an important cause of disability, the treatment of this complication represents a major challenge for neurological rehabilitation.
Conventional treatment of muscle stiffness, like passive mobilization, physical therapy, oral antispastic medication, serial casting, surgery and the intrathekal application of Baclofen, seems to be non-effective. Clinical trials showed that only Botulinum toxin (BTX) injection is an efficient therapy for muscle stiffness, but with limited effectiveness in severely affected chronic patients where the immobility-related changes of the mechanical muscle properties are prevailing. Furthermore, the BTX-treatment is expensive. Conventional electrical stimulation is not appropriate for being applied in spasticity, due to the specific condition of the skin of these patients, and do not give good results in spasticity (central neurological issue) as it does in the case of muscle stiffness associated with peripheral nerve-muscle-joint-bone acute or chronic conditions.
Repetitive magnetic stimulation of brain, skeletal muscles, peripheral nerves, or spinal roots, is a non-contact, non-invasive and painless method that can be an alternative in the management of muscle stiffness [8] . More than this, the magnetic stimulation device is easy to use and simple to apply. The painless and non-invasive repetitive peripheral magnetic stimulation (rPMS) has been successfully applied in neurologically impaired adults and children with cerebral palsy (CP) in order to reduce muscle tone improve motor function and perceptual cognitive tasks.
Struppler et al. reported positive effects of rPMS on upper limb spasticity and motor recovery in chronic stroke subjects and associate the improvements on muscle tone and motor control with a significant increase of neural activation [5, 6] . Other authors noticed clinical reduction of muscle tone at both ankles on children with cerebral palsy after they performed theta-burst stimulation with 900 pulses per minute [9] . It seems that rpMS decrease muscle stiffness and reduce sensitivity of the muscle spindles. Hagbarth et al. studied the thixotrophic phenomenon in healthy subjects [11] . To be published studies of Hesse et al. show that a single session of verum rPMS, in combination with manual muscle stretch,effects a significantly larger decrease of the joint extension deficit in chronic patients with severe spasticity, when compared to sham stimulation.
II. OBJECTIVE OF THE STUDY
This study's objective was to test whether rPMS, while stretching supra-maximal the target joints and accompanied by a routine rehabilitation, could lead to a reduction of muscle stiffness on a patient with SNC lesions.
III. METHOD
This study investigate two patients with severe and moderate-muscle stiffness, after stroke lesions.
Patient's characteristics:  The target joints of the upper and/or lower limb did not reach the neutral position when passively moved, even when applying a strong force. The corresponding value on the modified Ashworth score (0-5) was 3 or 4, i.e. the joint could be moved minimally, but was not fixed.  A conventional X-ray excluded an osseous joint contracture and/or a myositis ossificans.  A preceding Botulinum A toxin injection with a dosage according to national guidelines had not resulted in a relevant stiffness reduction. The time interval since the last injection was at least four months.  Any metal implants, deep vein thrombosis, open wounds and relevant edema in the extremities under investigation as well as pacemaker excluded the patient.  Patient understood and signed the written informed consent of the study, which was approved by the local ethical committee. Four target joints were studied, in order to assess knee flexor stiffness and plantar flexor stiffness.
IV. EXPERIMENTAL DESIGN
Initially the patient participated in a familiarization session, in order to be introduced with the study algorithm, the measurement protocol and the mechanism of the rPMS. Three investigators, two therapists and one MD, were responsible.
A Magstim Rapid stimulator with two circular coils (diameter 8 inches) delivered the rPMS. The coil was placed over the muscles corresponding to the target joint, the hamstrings and the plantar flexor group (in case of knee flexor stiffness) and the plantar flexor group (in case of plantar flexor stiffness). During the stimulation period, one therapist moved the target joint in the most outstretched position without eliciting pain. The coil was placed with the A-side on the limb and moved it parallel to the skin covering the targeted muscles. The patients received 10 sessions (1 time per day, ten days consecutive) of low-frequency rPMS on the affected muscle while the target joint was continuously stretched.
The stimulation parameters were: 60% intensity, 5Hz, 3s trains of stimulation and 3s pause, a total of 750 stimuli per targeted muscle group. The intensity was above the motor threshold. These stimulation parameters have been used in previous studies [12] .
V. OUTCOME MEASURES A blinded investigator assessed the patient while lying supine; the joint under investigation was positioned on a supportive pillow, after the patient had been instructed to extend the joint to their individual maximum. Given the poor interpretation reliability of the goniometer measurements, the same investigator made all the measurements all along the study.
Dependent variable were the relative active extension deficit and Modified Ashworth Scale of the muscles, assessed at baseline (when the patient received only physiotherapy), daily at a fixed time before and after stimulation, and 10 days later (T10).
All outcome measures were assessed 13 times: pre-intervention baseline assessments were repeated 5 days apart (T-10, T-5, T0), T1-direct after the 1 st session, T2-24 hours after the 1 st session, T3 -direct after 2 nd session, T4, T5 -before and after 5 th session, T6,T7 -before and after 9 th session, T8, T9 -before and after 10 th session. At each measurement point, the investigator assessed the extension deficit with the help of a goniometer at rest. Every assessment was followed by the joint repositioning on the supportive pillow, with no intervention.
VI. STATISTICS
As a first step, the extension deficit of each joint relative to the maximum anatomical joint flexion was calculated. The corresponding degrees of the lower limb joints were 150° (knee joint) and 30° (ankle plantar flexion). The relative extension deficit and the modified Ashworth score were calculated with the help of a computerized statistical program (SPSS 17.0).
VII. RESULTS
The patients completed the study with no adverse events from either aspect of intervention. During the baseline (time period T-10 to T0) the active extension deficit at rest did not decrease significantly (only with 5.76 %). Immediately deficit at rest decreased significantly (with 21.11 %). The positive effects following verum stimulation were fully sustained 3 hours later, at 24 hours the effects had waned but not yet reached the baseline values. A significantly larger decrease from baseline to T9 (of 75.65%) was observed (see Fig. 1 ). Fig. 1 . Graphical representation of progress of the extension deficit for knee joint during intervention period. The measurements are performed before and after each rPMS session.
The mean modified Ashworth scores showed a similar behavior, i.e. no significant change during the baseline, followed by a significant reduction after the verum stimulation. Muscle tone was reduced within the 10 days of stimulation with 1.25 points on the Ashworth score.
VIII. DISCUSSION
A single session of verum rPMS in combination with continuous joint stretch diminished significantly the extension deficit of the stiff joints.
The patients were in the chronic stage, i.e. spasticity in the sense of an altered muscle activity level and immobility-related muscle contractures with sarcopenia, both contributed to the clinical picture of inherent and reflex mediated muscle stiffness and limited range of joint mobility.
The chosen protocol of an exclusive stimulation of the flexor muscles at a frequency of 5 Hz and 600 stimuli per targeted muscle in combination with continuous muscle stretch followed the work of Zschorlich et al. in healthy subjects, they had noticed a reduced muscle tone and a diminished stretch reflex [12] .
The degree of spasticity at baseline seems to be a major predictor of the response to the rpMS intervention, irrespective of the stimulation protocol. Struppler et al. had studied patients with spasticity values by means of the modified Ashworth Scale between 3 and 5. In patients with initial modified Ashworth scores of 1 or 2 however, neither Krewer et al. nor Müller et al. found a relevant effect on muscle tone (both followed the Struppler protocol).
Muscle stretch itself reduced muscle stiffness and many recent studies showed that rPMS itself decrease muscle stiffness. Starting from this our further studies try to see if is a connection between different characteristics of the patient (i.e type of SNC lesion, age of the patients, number of the session of rPMs, different frequency of rPMS) and response of stimulation. In this case we observed positive effects after one single session of rPMS that were maintained after 24 hour, waned but not reached the baseline values. More important after every session the positive effect sum, so at the end of the 10 consecutives workdays sessions it was a significant decrease of muscle stiffness.
IX. CONCLUSION
For patients with residual spasticity after stroke repetitive peripheral magnetic stimulation is a safe and feasible approach which appears to provide positive effects, with no clear long term benefits.
Further studies with rPMS in larger and randomized population are required, to elucidate if combining rPMS while stretching is better alternative than rPMS without stretching in treatment of muscle stiffness is our next aim as well as to try to determinate the right parameters for patients depending on the characteristics of each.
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